POLCROVÁ, Anna, Iuliia PAVLOVSKA, Geraldo A. Maranhao NETO, Šárka KUNZOVÁ, Maria M. INFANTE-GARCIA, Jose R. MEDINA-INOJOSA, Francisco LOPEZ-JIMENEZ, Jeffrey I. MECHANICK, Ramfis NIETO-MARTINEZ, Gorazd Bernard STOKIN, Hynek PIKHART a Juan P. GONZALEZ-RIVAS. Visceral fat area and cardiometabolic risk: The Kardiovize study. Obesity Research & Clinical Practice. OXFORD: ELSEVIER SCI LTD, 2021, roč. 15, č. 4, s. 368-374. ISSN 1871-403X. Dostupné z: https://dx.doi.org/10.1016/j.orcp.2021.03.005.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Visceral fat area and cardiometabolic risk: The Kardiovize study
Autoři POLCROVÁ, Anna (203 Česká republika, garant, domácí), Iuliia PAVLOVSKA (804 Ukrajina, domácí), Geraldo A. Maranhao NETO (203 Česká republika), Šárka KUNZOVÁ (203 Česká republika), Maria M. INFANTE-GARCIA (862 Venezuela), Jose R. MEDINA-INOJOSA (840 Spojené státy), Francisco LOPEZ-JIMENEZ (840 Spojené státy), Jeffrey I. MECHANICK (840 Spojené státy), Ramfis NIETO-MARTINEZ (862 Venezuela), Gorazd Bernard STOKIN (203 Česká republika), Hynek PIKHART (203 Česká republika, domácí) a Juan P. GONZALEZ-RIVAS (840 Spojené státy).
Vydání Obesity Research & Clinical Practice, OXFORD, ELSEVIER SCI LTD, 2021, 1871-403X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30308 Nutrition, Dietetics
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.214
Kód RIV RIV/00216224:14310/21:00121420
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.1016/j.orcp.2021.03.005
UT WoS 000675529000010
Klíčová slova anglicky Intra-abdominal fat; Cardiometabolic risk factors; Race factors
Štítky 14110525, podil
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Michaela Hylsová, Ph.D., učo 211937. Změněno: 27. 1. 2022 22:15.
Anotace
Background: Visceral fat is associated with adiposity-based complications. Bioimpedance measurement allows estimation of visceral fat area (VFA) in an easy manner. However, a validated cut-off value for VFA by bioimpedance associated with cardiometabolic risk is lacking in European population. Aim: To determine cut-off values of VFA measured via bioimpedance associated with cardiometabolic risk. Methods: Random cross-sectional Czech population-based sample of 25-64 years old subjects. Receiver Operating Characteristic (ROC) curves were used and the area under the curve (AUC), sensitivity, and specificity were calculated. The Cardiometabolic Disease Staging System (CMDS) was used to classify cardiometabolic risk: Stage 1 - 1 or 2 metabolic syndrome (MetS) components, without impaired fasting glucose (IFG); Stage 2 - MetS or IFG; Stage 3 - MetS with IFG; Stage 4 - type 2 diabetes and/or cardiovascular disease. Results: 2052 participants (54.5% females, median age 49 years) were included. Median VFA (inter-quartile range) were 82.2 cm(2) (54.8) in men and 89.8 cm(2) (55.6) in women. The best VFA cut-offs associated with Stage 1 in men and women were 71 cm(2)(sensitivity = 0.654; specificity = 0.427) and 83 cm(2) (sensitivity = 0.705; specificity = 0.556); Stage 2: 84 cm(2) (sensitivity = 0.673; specificity = 0.551) and 98 cm(2) (sensitivity = 0.702; specificity = 0.628); Stage 3: 90 cm(2) (sensitivity = 0.886; specificity = 0.605) and 109 cm(2) (sensitivity = 0.755; specificity = 0.704); Stage 4: 91 cm(2)(sensitivity = 0.625; specificity = 0.611) and 81cm(2) (sensitivity = 0.695; specificity = 0.448), respectively. Conclusion: A cut-off value of VFA of 71 cm(2) in men and 83 cm(2) in women exhibited the earliest stage of cardiometabolic risk, and 90 cm(2) in men and 109 cm(2) in women showed the best performance to detect risk.
VytisknoutZobrazeno: 11. 5. 2024 17:04